Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial

Davine Hofste Op Bruinink; Mark van Duin; Meral Beksac; Christoph Driessen; Heinz Ludwig; Michael Vermeulen; Rowan Kuiper; Martin H. van Vliet; Bronno van der Holt; Roman Hajek; Hans Erik Johnsen; Meletios A. Dimopoulos; Antonio Palumbo; Michele Cavo; Pieter Sonneveld

doi:10.1182/blood-2018-99-119873

Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial

Davine Hofste Op Bruinink, Mark van Duin, Meral Beksac, Christoph Driessen, Heinz Ludwig, Michael Vermeulen, Rowan Kuiper, Martin H. van Vliet, Bronno van der Holt, Roman Hajek, Hans Erik Johnsen, Meletios A. Dimopoulos, Antonio Palumbo, Michele Cavo, Pieter Sonneveld

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Blood
Volume	132
Issue number	Suppl. 1
Pages (from-to)	3186
Number of pages	1
ISSN	0006-4971
DOIs	https://doi.org/10.1182/blood-2018-99-119873
Publication status	Published - Nov 2018
Event	60th ASH Annual Meeting & Exposition - San Diego, United States Duration: 1 Dec 2018 → 4 Dec 2018 Conference number: 60

Conference

Conference	60th ASH Annual Meeting & Exposition
Number	60
Country/Territory	United States
City	San Diego
Period	01/12/2018 → 04/12/2018

Access to Document

10.1182/blood-2018-99-119873

http://www.bloodjournal.org/content/132/Suppl_1/3186

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Bruinink, D. H. O., van Duin, M., Beksac, M., Driessen, C., Ludwig, H., Vermeulen, M., Kuiper, R., van Vliet, M. H., van der Holt, B., Hajek, R., Johnsen, H. E., Dimopoulos, M. A., Palumbo, A., Cavo, M., & Sonneveld, P. (2018). Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial. Blood, 132(Suppl. 1), 3186. https://doi.org/10.1182/blood-2018-99-119873

@article{03739fb108b84a4f96cd8509d5cf42fb,

title = "Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial",

author = "Bruinink, {Davine Hofste Op} and {van Duin}, Mark and Meral Beksac and Christoph Driessen and Heinz Ludwig and Michael Vermeulen and Rowan Kuiper and {van Vliet}, {Martin H.} and {van der Holt}, Bronno and Roman Hajek and Johnsen, {Hans Erik} and Dimopoulos, {Meletios A.} and Antonio Palumbo and Michele Cavo and Pieter Sonneveld",

note = "60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 01-04, 2018; 60th ASH Annual Meeting & Exposition ; Conference date: 01-12-2018 Through 04-12-2018",

year = "2018",

month = nov,

doi = "10.1182/blood-2018-99-119873",

language = "English",

volume = "132",

pages = "3186",

journal = "Blood",

issn = "0006-4971",

publisher = "AMER SOC HEMATOLOGY",

number = "Suppl. 1",

}

Bruinink, DHO, van Duin, M, Beksac, M, Driessen, C, Ludwig, H, Vermeulen, M, Kuiper, R, van Vliet, MH, van der Holt, B, Hajek, R, Johnsen, HE, Dimopoulos, MA, Palumbo, A, Cavo, M & Sonneveld, P 2018, 'Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial', Blood, vol. 132, no. Suppl. 1, pp. 3186. https://doi.org/10.1182/blood-2018-99-119873

Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial. / Bruinink, Davine Hofste Op; van Duin, Mark; Beksac, Meral et al.
In: Blood, Vol. 132, No. Suppl. 1, 11.2018, p. 3186.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial

AU - Bruinink, Davine Hofste Op

AU - van Duin, Mark

AU - Beksac, Meral

AU - Driessen, Christoph

AU - Ludwig, Heinz

AU - Vermeulen, Michael

AU - Kuiper, Rowan

AU - van Vliet, Martin H.

AU - van der Holt, Bronno

AU - Hajek, Roman

AU - Johnsen, Hans Erik

AU - Dimopoulos, Meletios A.

AU - Palumbo, Antonio

AU - Cavo, Michele

AU - Sonneveld, Pieter

N1 - Conference code: 60

PY - 2018/11

Y1 - 2018/11

U2 - 10.1182/blood-2018-99-119873

DO - 10.1182/blood-2018-99-119873

M3 - Conference abstract in journal

SN - 0006-4971

VL - 132

SP - 3186

JO - Blood

JF - Blood

IS - Suppl. 1

T2 - 60th ASH Annual Meeting & Exposition

Y2 - 1 December 2018 through 4 December 2018

ER -